Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages
Abstract Progressive supranuclear palsy (PSP) is a rare and rapidly progressing atypical parkinsonism. Albeit existing clinical criteria for PSP have good specificity and sensitivity, there is a need for biomarkers able to capture early objective disease-specific abnormalities. This study aimed to i...
Guardado en:
Autores principales: | Marianna Amboni, Carlo Ricciardi, Marina Picillo, Chiara De Santis, Gianluca Ricciardelli, Filomena Abate, Maria Francesca Tepedino, Giovanni D’Addio, Giuseppe Cesarelli, Giampiero Volpe, Maria Consiglia Calabrese, Mario Cesarelli, Paolo Barone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa390d462e7943688220817ee1b4d75d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding fatigue in progressive supranuclear palsy
por: Jong Hyeon Ahn, et al.
Publicado: (2021) -
A case of atypical progressive supranuclear palsy
por: Spaccavento S, et al.
Publicado: (2013) -
Positive impact of short-term gait rehabilitation in Parkinson patients: a combined approach based on statistics and machine learning
por: Leandro Donisi, et al.
Publicado: (2021) -
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
por: Gozes I, et al.
Publicado: (2012) -
Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry
por: Birthe Stemplewitz, et al.
Publicado: (2017)